On July 9, 2024, bluebird bio entered into a Second Amendment to its Loan and Security Agreement with Hercules Capital and other lenders. The amendment extends the timeline for providing monthly financial reporting metrics and deadlines for submitting financial statements for FY2023 and Q1-Q2 2024.Under the amended agreement, the company's delayed submission of Form 10-K for 2023 and Forms 10-Q for Q1 and Q2 2024 will not be considered a violation of compliance covenants, provided the documents are filed within the new extended deadlines. The amendment modifies the original loan agreement dated March 15, 2024, which was previously amended on April 30, 2024.

On July 9, 2024, bluebird bio entered into a Second Amendment to its Loan and Security Agreement with Hercules Capital and other lenders. The amendment extends the timeline for providing monthly financial reporting metrics and deadlines for submitting financial statements for FY2023 and Q1-Q2 2024.Under the amended agreement, the company's delayed submission of Form 10-K for 2023 and Forms 10-Q for Q1 and Q2 2024 will not be considered a violation of compliance covenants, provided the documents are filed within the new extended deadlines. The amendment modifies the original loan agreement dated March 15, 2024, which was previously amended on April 30, 2024.